To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Abroad (travel likely)Recruiting
Conditions
Pancreatic Adenocarcinoma · Peritoneal (Metastatic) Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Zhongshan Hospital, Fudan University, Shanghai, shangaiShanghai Municipality, China
Contact: Principal Investigator (Liang Liu, Dr.)Yaolin Xu, Dr. (Sub-investigator)Botton/Chamaplimaud Pancreatic cancer center, Lisbon, Lisbon District, Portugal
Contact: Study coordinator (Gil Gonçalves, MD) · Gil.goncalves@fundacaochampalimaud.pt · +351919362204Contact: Principal Investigator (Gil Gonçalves, MD)ULS São João, Porto, Portugal
Contact: Study coordinator (Tiago Bouça-Machado, MD) · tiago.machado@chsj.min-saude.pt · +351 225 512 100Contact: Principal Investigator (Tiago Bouça-Machado, MD)